Newsfeeds - Spark Newswire

1 minute read

Barclays Downgrades Ortho Clinical Diagnostic to Equal-Weight, Lowers Price Target to $25

Today, 2:35 AM

Barclays analyst Luke Sergott downgrades Ortho Clinical Diagnostic (NASDAQ:OCDX) from Overweight to Equal-Weight and lowers the price target from $29 to $25.

OCDX

1 minute read

Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights

By Vandana Singh

Today, 2:35 AM

Quidel Corp (NASDAQ: QDEL)

OCDX

5 minute read

UPDATE: Quidel To Buy Ortho Clinical Diagnostics At $24.68/Share In Cash, Newly-Issued Shares

By Benzinga Newsdesk

Today, 2:35 AM

Transaction Highlights Brings together highly complementary diagnostic portfolios with world-class technologies and platforms spanning high-throughput systems to near-patient and at-home testing. Provides

OCDX

1 minute read

Ortho Clinical Diagnostic Q3 EPS $0.21 Beats $0.14 Estimate, Sales $522.50M Beat $481.71M Estimate

By Benzinga Newsdesk

Today, 2:35 AM

Ortho Clinical Diagnostic (NASDAQ:OCDX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.14 by 50 percent. The company reported quarterly sales of $522.50 million which beat

OCDX

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 2:35 AM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 2:35 AM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

4 minute read

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

By Shanthi Rexaline

Today, 2:35 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

ABSI

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:35 AM

Gainers

ABUS

1 minute read

Benzinga Pro’s Top 5 Stocks To Watch For Thursday, Aug. 5, 2021: AMC, OLB, EXPI, OCDX, GENI

By Benzinga Newsdesk

Today, 2:35 AM

Today's 5 Stock Ideas: AMC Entertainment (AMC) - Shares rebounded from a pre-market low at $28.50 and traded over the $30 level. The stock was up about 2.5% Thursday morning. The Benzinga newsteam did

AMC

2 minute read

FDA
News

Ortho Clinical Diagnostics Reports Expansion Of Its COVID-19 Test Offerings With Emergency Use Authorization Of Total Nucleocapsid Antibody Test

By Benzinga Newsdesk

Today, 2:35 AM

-- Ortho's new VITROS® Anti-SARS-CoV-2 Total N test detects the individual's immune response to the COVID-19 virus and is intended to help clinicians understand if their patient had a recent or

OCDX